MPO inhibitors preserve endothelial function in mouse models of atherosclerosis with intact renal function by oxidizing soluble guanylyl cyclase resulting in improvement in plaque area, cytokine levels, and oxidative stress (59, 64, 77, 78). The gene discussed is MPO; the disease is atherosclerosis.